AR-226-1260 - The letter describes DuPont's telomer-based products manufacturing locations in the United States which are part of the TRP Characterizing Potential Release of PFOA from Telomer-Based Product Manufacture described in the voluntary Commitment, Item 3, on page 4 in the 14 March 2003 LOT to the Agency by TRP
EPA-HQ-OPPT-2020-0490-1213Supporting & Related Material
Document
Details
The document's own metadata, straight from the source system.
- Title
- AR-226-1260 - The letter describes DuPont's telomer-based products manufacturing locations in the United States which are part of the TRP Characterizing Potential Release of PFOA from Telomer-Based Product Manufacture described in the voluntary Commitment, Item 3, on page 4 in the 14 March 2003 LOT to the Agency by TRP
- Posted
- Jul 22, 2026
- Topics
- Animal Health & Welfare
- Biomedical Research
- Chemical & Toxic Substances
- Food Safety & Nutrition
- Household Chemical Safety
- Manufacturing & Supply Chains
- Pharmaceutical Policy
- Product Safety & Recalls
- Public Health Infrastructure & Data
- Tax Policy & Reform
- Water Quality & Infrastructure
- Endangered Species & Wildlife
- Workplace Safety & OSHA